Big News from CIBSS! The start-up EMUNO Therapeutics GmbH, founded by #CIBSS member Olaf Groß and Emilia Neuwirth (CEO) will be advancing research on EMT-224 – a promising drug candidate for #ColonCancer – with a prestigious #EICTransition Grant by the #EuropeanInnovationCouncil

https://kurzlinks.de/h56v